Researchers Outline Novel Treatment Approaches Being Studied in Myelofibrosis

October 24, 2020 12:00pm

Their study outlines several treatments being investigated for the treatment of patients with myelofibrosis and other myeloproliferative neoplasms, generally after they have become resistant or intolerant to Janus kinase inhibition.

Finerenone Slows Progression in CVD, Reduces CV Events, Study Says
Dr Guofen Yan On the Mechanism Behind Racial Disparities in ESKD Incidence
Dr Lametra Scott Discusses Cost, Formulary Guidance in Managing Sickle Cell Disease
Prescribing Patterns for Second-Line Treatment of Rheumatoid Arthritis

Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs

October 23, 2020

In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.

Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD

October 23, 2020

The investigational drug finerenone met its primary endpoint in FIDELIO-DKD of slowing progression of chronic kidney disease (CKD) in patients with type 2 diabetes and CKD, said Rajiv Agarwal, MD, MS, FASN, a professor of medicine at Indiana University School of Medicine and a staff physician at the Veterans Affairs Medical Center in Indianapolis, Indiana.